The company gained 4.4 billion euros in sales in 2010, with its Hospital Care and Aesculap division representing the largest contributors to growth. The company was able to expand its workforce and increase spending on research and development last year while also bolstering worldwide production capacity.
The company announced last month that it will be investing 50 million euros into expanding its manufacturing and logistics facilities in Glandorf, Germany.
Read the Zenopa release about B. Braun.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.